AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury
Hepatology
.
2023 Mar 1;77(3):1036-1065.
doi: 10.1002/hep.32689.
Epub 2023 Feb 17.
Authors
Robert J Fontana
1
,
Iris Liou
2
,
Adrian Reuben
3
,
Ayako Suzuki
4
,
M Isabel Fiel
5
,
William Lee
6
,
Victor Navarro
7
Affiliations
1
Division of Gastroenterology and Hepatology , University of Michigan , Ann Arbor , Michigan , USA.
2
University of Washington , Seattle , Washington , USA.
3
Department of Medicine , Medical University of South Carolina , Charleston , South Carolina , USA.
4
Division of Gastroenterology , Duke University , Durham , North Carolina , USA.
5
Department of Pathology , Mount Sinai School of Medicine , New York City , New York , USA.
6
Division of Gastroenterology , University of Texas Southwestern , Dallas , Texas , USA.
7
Department of Medicine , Einstein Healthcare Network , Philadelphia , Pennsylvania , USA.
PMID:
35899384
PMCID:
PMC9936988
DOI:
10.1002/hep.32689
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Chemical and Drug Induced Liver Injury* / etiology
Chemical and Drug Induced Liver Injury, Chronic*
Dietary Supplements / adverse effects
Humans